{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:22:34Z","timestamp":1777533754187,"version":"3.51.4"},"reference-count":16,"publisher":"Japanese Pharmacological Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1254\/jphs.11200sc","type":"journal-article","created":{"date-parts":[[2012,1,27]],"date-time":"2012-01-27T05:20:22Z","timestamp":1327641622000},"page":"295-298","source":"Crossref","is-referenced-by-count":27,"title":["The Selective Metabotropic Glutamate 2\/3 Receptor Agonist MGS0028 Reverses Isolation Rearing\u2013Induced Abnormal Behaviors in Mice"],"prefix":"10.1254","volume":"118","author":[{"given":"Yukio","family":"Ago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Chaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuro","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akemichi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Takuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.12.041"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2008.03.003"},{"issue":"3","key":"3","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(24)38052-8","volume":"288","author":"MILLAN M J","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2010.10.009"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1021\/jm000346k"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2295-3"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.89.89"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.11R01CR"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1349"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Swanson CJ, Schoepp DD. A role for noradrenergic transmission in the actions of phencyclidine and the antipsychotic and antistress effects of mGlu2\/3 receptor agonists. Ann N Y Acad Sci. 2003;1003:309–317.","DOI":"10.1196\/annals.1300.019"},{"issue":"1","key":"11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3565(24)35262-0","volume":"292","author":"MAREK G J","year":"2000","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1038\/nature06612"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-1931-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Ossowska K, Pietraszek M, Wardas J, Nowak G, Zajaczkowski W, Wolfarth S, et al. The role of glutamate receptors in antipsychotic drug action. Amino Acids. 2000;19:87–94.","DOI":"10.1007\/s007260070037"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, et al. Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med. 2007;13:1102–1107.","DOI":"10.1038\/nm1632"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kinon BJ, Zhang L, Millen BA, Osuntokun OO, Williams JE, Kollack-Walker S, et al. A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia. J Clin Psychopharmacol. 2011;31:349–355.","DOI":"10.1097\/JCP.0b013e318218dcd5"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:22:13Z","timestamp":1742376133000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/118\/2\/118_11200SC\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.11200sc","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}